Jade Biosciences, Inc.
JBIO
$15.26
$0.040.26%
NASDAQ
| 03/31/2026 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 119.93% | 184.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 85.79% | 76.16% | |||
| Operating Income | -85.79% | -76.16% | |||
| Income Before Tax | -5.72% | -49.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.76% | -49.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.76% | -49.26% | |||
| EBIT | -85.79% | -76.16% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 95.26% | 90.98% | |||
| Normalized Basic EPS | 90.32% | 86.77% | |||
| EPS Diluted | 95.26% | 90.98% | |||
| Normalized Diluted EPS | 90.32% | 86.77% | |||
| Average Basic Shares Outstanding | 1,731.00% | 1,154.46% | |||
| Average Diluted Shares Outstanding | 1,731.00% | 1,154.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||